-
1
-
-
84857984149
-
Dyslipidemia in patients with nonalcoholic fatty liver disease
-
Chatrath H., Vuppalanchi R., Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis 2012, 32(1):22-29.
-
(2012)
Semin Liver Dis
, vol.32
, Issue.1
, pp. 22-29
-
-
Chatrath, H.1
Vuppalanchi, R.2
Chalasani, N.3
-
2
-
-
84877854022
-
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
-
Gaggini M., Morelli M., Buzzigoli E., DeFronzo R.A., Bugianesi E., Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013, 5(5):1544-1560.
-
(2013)
Nutrients
, vol.5
, Issue.5
, pp. 1544-1560
-
-
Gaggini, M.1
Morelli, M.2
Buzzigoli, E.3
DeFronzo, R.A.4
Bugianesi, E.5
Gastaldelli, A.6
-
3
-
-
84886558949
-
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
-
Kawano Y., Cohen D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. JGastroenterol 2013, 48(4):434-441.
-
(2013)
JGastroenterol
, vol.48
, Issue.4
, pp. 434-441
-
-
Kawano, Y.1
Cohen, D.E.2
-
4
-
-
57049172674
-
Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle
-
Rome S., Lecomte V., Meugnier E., Rieusset J., Debard C., Euthine V., et al. Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol Genomics 2008, 34(3):327-337.
-
(2008)
Physiol Genomics
, vol.34
, Issue.3
, pp. 327-337
-
-
Rome, S.1
Lecomte, V.2
Meugnier, E.3
Rieusset, J.4
Debard, C.5
Euthine, V.6
-
5
-
-
0028225462
-
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis
-
Wang X., Sato R., Brown M.S., Hua X., Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994, 77(1):53-62.
-
(1994)
Cell
, vol.77
, Issue.1
, pp. 53-62
-
-
Wang, X.1
Sato, R.2
Brown, M.S.3
Hua, X.4
Goldstein, J.L.5
-
6
-
-
13144281703
-
Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis
-
Cases S., Smith S.J., Zheng Y.W., Myers H.M., Lear S.R., Sande E., et al. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A 1998, 95(22):13018-13023.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, Issue.22
, pp. 13018-13023
-
-
Cases, S.1
Smith, S.J.2
Zheng, Y.W.3
Myers, H.M.4
Lear, S.R.5
Sande, E.6
-
7
-
-
0035914356
-
Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members
-
Cases S., Stone S.J., Zhou P., Yen E., Tow B., Lardizabal K.D., et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. Biol Chem 2001, 276(42):38870-38876.
-
(2001)
Biol Chem
, vol.276
, Issue.42
, pp. 38870-38876
-
-
Cases, S.1
Stone, S.J.2
Zhou, P.3
Yen, E.4
Tow, B.5
Lardizabal, K.D.6
-
8
-
-
0036183630
-
The mechanisms of action of PPARs
-
Berger J., Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 2002, 53:409-435.
-
(2002)
Annu Rev Med
, vol.53
, pp. 409-435
-
-
Berger, J.1
Moller, D.E.2
-
9
-
-
0030047806
-
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
-
Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137(1):354-366.
-
(1996)
Endocrinology
, vol.137
, Issue.1
, pp. 354-366
-
-
Braissant, O.1
Foufelle, F.2
Scotto, C.3
Dauça, M.4
Wahli, W.5
-
10
-
-
0032699670
-
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting
-
Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., Wahli W.J. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. JClin Invest 1999, 103(11):1489-1498.
-
(1999)
JClin Invest
, vol.103
, Issue.11
, pp. 1489-1498
-
-
Kersten, S.1
Seydoux, J.2
Peters, J.M.3
Gonzalez, F.J.4
Desvergne, B.5
Wahli, W.J.6
-
11
-
-
32644443742
-
Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression
-
Patsouris D., Reddy J.K., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006, 147(3):1508-1516.
-
(2006)
Endocrinology
, vol.147
, Issue.3
, pp. 1508-1516
-
-
Patsouris, D.1
Reddy, J.K.2
Müller, M.3
Kersten, S.4
-
12
-
-
0034530972
-
Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators
-
Lazennec G., Canaple L., Saugy D., Wahli W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol 2000, 14(12):1962-1975.
-
(2000)
Mol Endocrinol
, vol.14
, Issue.12
, pp. 1962-1975
-
-
Lazennec, G.1
Canaple, L.2
Saugy, D.3
Wahli, W.4
-
13
-
-
0036667350
-
Evidence for cross talk between PPARalpha and p38 MAP kinase
-
Roberts R.A. Evidence for cross talk between PPARalpha and p38 MAP kinase. Toxicol Sci 2002, 68(2):270-274.
-
(2002)
Toxicol Sci
, vol.68
, Issue.2
, pp. 270-274
-
-
Roberts, R.A.1
-
14
-
-
33244494398
-
PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes
-
Edvardsson U., Ljungberg A., Lindén D., William-Olsson L., Peilot-Sjögren H., Ahnmark A., et al. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes. JLipid Res 2006, 47(2):329-340.
-
(2006)
JLipid Res
, vol.47
, Issue.2
, pp. 329-340
-
-
Edvardsson, U.1
Ljungberg, A.2
Lindén, D.3
William-Olsson, L.4
Peilot-Sjögren, H.5
Ahnmark, A.6
-
15
-
-
0022358190
-
The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes
-
Hertz R., Arnon J., Bar-Tana J. The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes. Biochim Biophys Acta 1985, 836(2):192-200.
-
(1985)
Biochim Biophys Acta
, vol.836
, Issue.2
, pp. 192-200
-
-
Hertz, R.1
Arnon, J.2
Bar-Tana, J.3
-
16
-
-
0036260018
-
Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities
-
Waterman I.J., Zammit V.A. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities. Diabetes 2002, 51(6):1708-1713.
-
(2002)
Diabetes
, vol.51
, Issue.6
, pp. 1708-1713
-
-
Waterman, I.J.1
Zammit, V.A.2
-
17
-
-
63849262635
-
Structure, function and antagonists of urokinase-type plasminogen activator
-
Vincenza Carriero M., Franco P., Vocca I., Alfnano D., Longanesi-Cattani I., Bifulco K., et al. Structure, function and antagonists of urokinase-type plasminogen activator. Front Biosci 2009, 14:3782-3794.
-
(2009)
Front Biosci
, vol.14
, pp. 3782-3794
-
-
Vincenza Carriero, M.1
Franco, P.2
Vocca, I.3
Alfnano, D.4
Longanesi-Cattani, I.5
Bifulco, K.6
-
18
-
-
84859812544
-
The urokinase system in the pathogenesis of atherosclerosis
-
Fuhrman B. The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis 2012, 222(1):8-14.
-
(2012)
Atherosclerosis
, vol.222
, Issue.1
, pp. 8-14
-
-
Fuhrman, B.1
-
19
-
-
84885355805
-
Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents ox-LDL-induced macrophage apoptosis
-
Paland N., Aharoni S., Fuhrman B. Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents ox-LDL-induced macrophage apoptosis. Atherosclerosis 2013, 231(1):29-38.
-
(2013)
Atherosclerosis
, vol.231
, Issue.1
, pp. 29-38
-
-
Paland, N.1
Aharoni, S.2
Fuhrman, B.3
-
20
-
-
36049037332
-
Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner
-
Fuhrman B., Nitzan O., Karry R., Volkova N., Dumler I., Aviram M. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis 2007, 195(2):e108-e116.
-
(2007)
Atherosclerosis
, vol.195
, Issue.2
, pp. e108-e116
-
-
Fuhrman, B.1
Nitzan, O.2
Karry, R.3
Volkova, N.4
Dumler, I.5
Aviram, M.6
-
21
-
-
46249131854
-
Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism
-
Fuhrman B., Khateeb J., Shiner M., Nitzan O., Karry R., Volkova N., et al. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Arterioscler Thromb Vasc Biol 2008, 28(7):1361-1367.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, Issue.7
, pp. 1361-1367
-
-
Fuhrman, B.1
Khateeb, J.2
Shiner, M.3
Nitzan, O.4
Karry, R.5
Volkova, N.6
-
22
-
-
84856228776
-
Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export
-
Khateeb J., Kiyan Y., Aviram M., Tkachuk S., Dumler I., Fuhrman B. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export. Arterioscler Thromb Vasc Biol 2012, 32(2):449-458.
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, Issue.2
, pp. 449-458
-
-
Khateeb, J.1
Kiyan, Y.2
Aviram, M.3
Tkachuk, S.4
Dumler, I.5
Fuhrman, B.6
-
23
-
-
84893873931
-
Urokinase-type plasminogen activator (uPA) decreases hepatic SR-BI expression and impairs HDL-mediated reverse cholesterol transport
-
Chulsky S., Paland N., Lazarovich A., Fuhrman B. Urokinase-type plasminogen activator (uPA) decreases hepatic SR-BI expression and impairs HDL-mediated reverse cholesterol transport. Atherosclerosis 2013, 233:11-18.
-
(2013)
Atherosclerosis
, vol.233
, pp. 11-18
-
-
Chulsky, S.1
Paland, N.2
Lazarovich, A.3
Fuhrman, B.4
-
24
-
-
84865227832
-
Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells
-
Wurie H.R., Buckett L., Zammit V.A. Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells. FEBS J 2012, 279(17):3033-3047.
-
(2012)
FEBS J
, vol.279
, Issue.17
, pp. 3033-3047
-
-
Wurie, H.R.1
Buckett, L.2
Zammit, V.A.3
-
25
-
-
21844462601
-
The inhibition of diacylglycerol acyltransferase by terpenoids from youngia koidzumiana
-
Dat N.T., Cai X.F., Rho M.C., Lee H.S., Bae K., Kim Y.H. The inhibition of diacylglycerol acyltransferase by terpenoids from youngia koidzumiana. Arch Pharm Res 2005, 28(2):164-168.
-
(2005)
Arch Pharm Res
, vol.28
, Issue.2
, pp. 164-168
-
-
Dat, N.T.1
Cai, X.F.2
Rho, M.C.3
Lee, H.S.4
Bae, K.5
Kim, Y.H.6
-
26
-
-
78149347693
-
Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease
-
Wang Z., Yao T., Song Z. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease. JLipid Res 2010, 51(11):3158-3165.
-
(2010)
JLipid Res
, vol.51
, Issue.11
, pp. 3158-3165
-
-
Wang, Z.1
Yao, T.2
Song, Z.3
-
27
-
-
1642523683
-
Lipopenia and skin barrier abnormalities in DGAT2-deficient mice
-
Stone S.J., Myers H.M., Watkins S.M., Brown B.E., Feingold K.R., Elias P.M., et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. Biol Chem 2004, 279(12):11767-11776.
-
(2004)
Biol Chem
, vol.279
, Issue.12
, pp. 11767-11776
-
-
Stone, S.J.1
Myers, H.M.2
Watkins, S.M.3
Brown, B.E.4
Feingold, K.R.5
Elias, P.M.6
-
28
-
-
34547946930
-
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
-
Choi C.S., Savage D.B., Kulkarni A., Yu X.X., Liu Z.X., Morino K., et al. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. JBiol Chem 2007, 282(31):22678-22688.
-
(2007)
JBiol Chem
, vol.282
, Issue.31
, pp. 22678-22688
-
-
Choi, C.S.1
Savage, D.B.2
Kulkarni, A.3
Yu, X.X.4
Liu, Z.X.5
Morino, K.6
-
29
-
-
22544473888
-
Arole for PPARalpha in the control of SREBP activity and lipid synthesis in the liver
-
Knight B.L., Hebbachi A., Hauton D., Brown A.M., Wiggins D., Patel D.D., et al. Arole for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. Biochem J 2005, 389(Pt 2):413-421.
-
(2005)
Biochem J
, vol.389
, pp. 413-421
-
-
Knight, B.L.1
Hebbachi, A.2
Hauton, D.3
Brown, A.M.4
Wiggins, D.5
Patel, D.D.6
-
30
-
-
34547105833
-
Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis
-
Payne V.A., Au W.S., Gray S.L., Nora E.D., Rahman S.M., Sanders R., et al. Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis. JBiol Chem 2007, 282(29):21005-21014.
-
(2007)
JBiol Chem
, vol.282
, Issue.29
, pp. 21005-21014
-
-
Payne, V.A.1
Au, W.S.2
Gray, S.L.3
Nora, E.D.4
Rahman, S.M.5
Sanders, R.6
|